Doris Molina-Henry will present at the 2024 American College of Neuropsychopharmacology's (ACNP) Annual Meeting. The group study session, Will Recent Therapeutic Advances Change the Clinical Course of Alzheimer’s Disease, explores the evidence for cognitive training, physical exercise, and other lifestyle interventions in preventing and treating cognitive decline and dementia in older adults. The annual event, […]
The IMPACT-AD 2025 Informational Webinar is a fantastic opportunity for anyone passionate about making a difference in Alzheimer's and related dementias (ADRD) clinical trials. This free online webinar on January 14, 2025 (10:00 AM – 11:00 AM PST) is your chance to: Learn more about the IMPACT-AD program: Get a comprehensive overview of the curriculum, application […]
Doris Molina-Henry will be presenting at the Human Amyloid Imaging (HAI) 2025 Conference on Friday, January 17 in San Juan, Puerto Rico. The HAI Conference brings together leading researchers in the field of human amyloid imaging. Molina-Henry's presentation, titled "Racial and ethnicity differences in plasma biomarker eligibility prior to amyloid PET imaging in the AHEAD […]
